Ying-Yi Zhang

Expression of 5-lipoxygenase in pulmonary artery endothelial cells.

5-Lipoxygenase and human pulmonary artery endothelial cell proliferation.

Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.

Serial noninvasive assessment of progressive pulmonary hypertension in a rat model.

Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide.

Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis.

Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats.

Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.

Mutation analysis of the human 5-lipoxygenase C-terminus: support for a stabilizing C-terminal loop.

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice.

Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses.

MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.

Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression.

Nanoglycan complex formulation extends VEGF retention time in the lung.

Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo.

Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation.

[Change of serum TGF-beta1 and TNF-alpha in silicosis patients].

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis.

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy.

SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.

[Clinical efficacy of tetrandrine combined with acetylcysteine effervescent tablets in treatment of silicosis].

[Changes in activities of SOD and GSH-Px in induced sputum and their significance among silicosis patients].

Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.

Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease.

Myxoid liposarcoma in the abdominal wall: a case report.